Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

August 2019

Open Targets: Accelerating Drug Discoveries and Health Breakthroughs

Dr Ian Dunham, Open Targets director, presented Open Targets, a large-scale public-private consortium between leading organisations in bioinformatics, genomics, and pharmaceuticals. Open Targets has a vision of transforming the drug industry through the prioritisation and systematic identification of drug targets, the crucial first step in new drug discovery. Drawing on his nearly three decades of experience in the field, Dr Dunham discussed the ways data integration and pre-competitive collaboration across private and public organizations can accelerate drug discovery. The research will feed directly into the European Commission’s Open Science Monitor project, which seeks to value the impact and effect of open science.

WATCH NOW
Watch Open Targets: Accelerating Drug Discoveries and Health Breakthroughs